MedTrace Logo

Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

NCT03081455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2017-08-08

No results posted yet for this study

Summary

A prospective, non-interventional study to evaluate the impact of a process engineering intervention on screening and testing outcomes for common hereditary cancer syndromes in community-based OB/GYN settings.

Conditions

  • Hereditary Cancer

Interventions

DIAGNOSTIC_TEST

Diagnostic Test

Genetic Diagnostic Testing

Sponsors & Collaborators

  • Myriad Genetics, Inc.

    collaborator INDUSTRY

  • Myriad Genetic Laboratories, Inc.

    lead INDUSTRY

Principal Investigators

  • Rocye T. Adkins, MD · Myriad Genetics, Inc.

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-13
Primary Completion
2017-07-07
Completion
2017-08-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03081455 on ClinicalTrials.gov